MariaSolAndres1 Profile Banner
Maria Sol Andres MD, MSc 🇦🇷🇬🇧 Profile
Maria Sol Andres MD, MSc 🇦🇷🇬🇧

@MariaSolAndres1

Followers
659
Following
2K
Media
268
Statuses
1K

Medical Doctor, Cardio-Oncology specialist. Chief of Cardio-Oncology Fellows @ Royal Brompton Hospital.

London, England
Joined February 2019
Don't wanna be here? Send us removal request.
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
5 years
“The secret of caring for the patient is caring for the patient” Dr. Francis Peabody.
0
0
10
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
5 days
Hot off the press! I’m excited to share our latest publication on immune checkpoint inhibitors and cardiovascular adverse events, a comprehensive, up-to-date review of the current evidence and emerging insights in the field. https://t.co/QxYEH5Pcu1 #cardioonc #cardiotox #cancer
1
1
8
@costgallo
Costanza
14 days
Been in Buenos Aires for less than 2 hours and I already decided I want to move here
266
227
10K
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
17 days
Felicitaciones @jamoukarzel Gran trabajo!!
@jamoukarzel
Juan Moukarzel 🇦🇷💙
17 days
Insuficiencia cardíaca e insuficiencia tricuspídea: revisión y estado actual por el Heart Team del #SanatorioMaterDei https://t.co/JInBjk0vTO
0
0
2
@ICOSociety
International Cardio-Oncology Society
28 days
Thank you to everyone who attended #GCOS25! We look forward to seeing you next year in Williamsburg, Virginia, USA! Thank you to everyone who made this #GCOS possible, including our South African partners @cososa_society and our social ambassador team.
0
2
6
@ICOSociety
International Cardio-Oncology Society
28 days
Thank you, #GCOS25! You’ve all made the first #GCOS on the African continent a smashing success. #cardioonc #cardiooncology #cardiooncologia #kardioonkologie #cardiooncologie
0
1
6
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
28 days
Dr. Sebastian Szmit’s excellent talk on Venous Thromboembolism (VTE) in cancer patients. 🩸🎗️ When lifelong or extended anticoagulation is needed, what’s the best approach? The API-CAT trial shows that reduced-dose Apixaban is non-inferior to full dose for preventing recurrent
2
5
11
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
28 days
Day 3 Global Cardio-Oncology Summit Session 6: Common cardiac toxicities QTc Prolongation How to EASILY measure the QT inverval by Dr. Plummer (UK) >> see below!! @ICOSociety #GCOS2025 @sdent_cardioonc @Dr_Mike_Fradley
0
4
13
@Dr_Mike_Fradley
Mike Fradley, MD
28 days
Day 3 of #gcos2025 starting now! Congrats @TeresaLpezFdez1 winner of the 2025 Thomas Force Award. Your dedication and impact to #cardioonc are truly profound! Thank you for everything @ICOSociety @sdent_cardioonc @escardio
0
6
21
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
28 days
Dr. Teresa Lopez Fernandez, guiding us on how to use multimodality imaging in cardio-oncology. It's all about selecting the right tool for the job! #GCOS2025 #cardioonc @ICOSociety @oncology_cardio @slumberbell @Dr_Mike_Fradley
@ICOSociety
International Cardio-Oncology Society
28 days
Day 3 of #GCOS25 starts now! Join us for the kickoff with Alexander Lyon 🇬🇧 & Trishun Singh 🇿🇦 to kick off the last day of this year's meeting. #GCOS2025 #cardioonc #cardiooncology #cardiooncologie #cardiooncologia #kardioonkologie
0
6
17
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
Can’t wait for the next stops on the Global Cardio-Oncology journey! 🌍 📍 2026: Virginia, USA 🇺🇸 📍 2027: Tokyo, Japan 🇯🇵 #GCOS2025 #cardioonc @ksase @ICOSociety @Dr_Mike_Fradley
0
6
16
@ICOSociety
International Cardio-Oncology Society
29 days
🌟A First at #GCOS2025🌟 The ICOS and European Society of Cardiology (@escardio) held a joint session on best practices and the future of #cardiooncology. With our societies working together, we can continue to help drive better outcomes for the hearts of #cancer patients.
1
9
27
@slumberbell
Novi Yanti Sari
29 days
Joint session @ICOSociety × #ESCardioOnco at #GCOS25 🫀 @Dr_Mike_Fradley delivered a practical breakdown of the @escardio #CardioOncology guidelines: 📍Prioritize Class I (do) vs Class III (don’t) 📍Baseline CV risk assessment for all patients 📍“Permissive cardiotoxicity” when
3
12
18
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
Day 2 #GCOS2025 The great debate with @sdent_cardioonc and @md_arianemacedo has just started! Do not miss it!!! #anthracyclines #cardioonc @ICOSociety
0
4
10
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
Exercise: the forgotten treatment 🏃‍♀️❤️ Dr. Erin Howden highlights the power of exercise in preventing cardiovascular disease among cancer patients. A simple, yet often overlooked, intervention with a profound impact on outcomes. #GCOS2025 #cardioonc @ICOSociety
0
5
12
@Dr_Mike_Fradley
Mike Fradley, MD
29 days
Dr Anju Nohria providing survivorship pearls @ICOSociety @MariaSolAndres1 #gcos2025 #cardioonc
0
7
16
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
PRIMARY CARE in #CardioOnc — highlights from the great @drtarsh Key messages 💡 1️⃣ Primary care physicians are the first point of contact for patients. 2️⃣ Early recognition of cardiovascular (and systemic) side effects of cancer therapy = 🔑 — education is essential. 3️⃣
1
3
6
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
Session 1 of day 2 at GCOS 2025 “When should I call the cardio-oncologist?” *Novel oncology trials are exploding —> cancer survivorship is increasing—> 53.5 M in 2022 *Cancer survivors die of CV disease *CV disease related to cancer therapy —> MULTIFACATORIAL *Multiple short
0
4
5
@MariaSolAndres1
Maria Sol Andres MD, MSc 🇦🇷🇬🇧
29 days
Day 2 has started Now keynote lecture “Access to Oncology Care a Global Perspective” by Dr Susannah Stanway @SusannahStanwa1 and a packed room! #GCOS2025 #cardioonc @ICOSociety
0
5
12